• ქართული
  • English
  • Biogen quarterly sales rise 9 percent

    Biogen Inc reported a 9 percent rise in quarterly revenue on Tuesday, helped by demand for its spinal muscular atrophy drug Spinraza.

    Market Quotes by TradingView